Peptide Receptor Radionuclide Therapy of Differentiated Thyroid Cancer: Efficacy and Toxicity

In rare cases of differentiated thyroid carcinoma (DTC), radioiodine treatment is no longer effective due to cell dedifferentiation. Targeting somatostatin receptors in DTC cells by radiolabelled somatostatin analogues could provide an alternative therapy option. The aim of this study was to evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Czepczyński, Rafał, Matysiak-Grześ, Magdalena, Gryczyńska, Maria, Bączyk, Maciej, Wyszomirska, Anna, Stajgis, Marek, Ruchała, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Basel 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359293/
https://www.ncbi.nlm.nih.gov/pubmed/25403743
http://dx.doi.org/10.1007/s00005-014-0318-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359293/
https://www.ncbi.nlm.nih.gov/pubmed/25403743
http://dx.doi.org/10.1007/s00005-014-0318-6

Ejemplares similares